Achieve Life Sciences, Inc. ACHV
$7.25
+8.37%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-08-14 | View → |
| 424B5 | 424B5 | 2026-08-14 | View → |
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 8-K | 8-K | 2026-07-06 | View → |
| DEF 14A | DEF 14A | 2026-06-08 | View → |
| 4 | 4 | 2026-06-02 | View → |
| 4 | 4 | 2026-06-02 | View → |
| 8-K | 8-K | 2026-06-02 | View → |
| 4 | 4 | 2026-05-13 | View → |
| S-3 | S-3 | 2026-05-12 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| 4 | 4 | 2026-04-21 | View → |
| 8-K | 8-K | 2026-04-16 | View → |
| 10-K | 10-K | 2026-03-24 | View → |
| 8-K | 8-K | 2026-03-24 | View → |
| 4 | 4 | 2026-01-30 | View → |
| 4 | 4 | 2026-01-30 | View → |
| 4 | 4 | 2026-01-30 | View → |
| 4 | 4 | 2026-01-30 | View → |
| 4 | 4 | 2026-01-30 | View → |
| 4 | 4 | 2026-01-30 | View → |
| S-3 | S-3 | 2026-01-23 | View → |
| 4 | 4 | 2025-12-08 | View → |
| 10-Q | 10-Q | 2025-11-06 | View → |
| 8-K | 8-K | 2025-11-06 | View → |
| 8-K | 8-K | 2025-10-07 | View → |
| 4 | 4 | 2025-10-03 | View → |
| 4 | 4 | 2025-09-22 | View → |
| 4 | 4 | 2025-09-22 | View → |
| 8-K | 8-K | 2025-09-11 | View → |
| 4 | 4 | 2025-09-08 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $7.25
- Market Cap
- $686.79 million
- 52-Week Range
- $2.25 – $7.33
- Average Volume
- 1.33 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.